MODERN VIEW ON THE PROBLEM OF DIAGNOSIS IN PATIENTS WITH ANGIOFIBROMA OF THE NASOPHARYNX BY DETECTING POLYMORPHISM OF THE GSTM1 GENE
Keywords:
nasopharyngeal angiofibroma, GSTM1 gene polymorphism, xenobiotic metabolism, antioxidant defense, molecular markers, personalized treatmentAbstract
Nasopharyngeal angiofibroma is a rare but potentially dangerous disease that requires accurate diagnosis and effective treatment methods. Current diagnostic approaches are mainly based on visual and morphological techniques, but the use of molecular markers, such as GSTM1 gene polymorphism, opens new perspectives in this field. Genes involved in xenobiotic metabolism and antioxidant defense play a role in the development of tumor diseases, including angiofibroma. The GSTM1 gene polymorphism, specifically its deletion, may be associated with an increased risk of tumor development, highlighting its significance as a diagnostic marker. This review presents an overview of the current diagnostic methods for nasopharyngeal angiofibroma and discusses the potential applications of GSTM1 polymorphism in improving prognosis, individualizing treatment, and enhancing therapeutic effectiveness. Further research on the role of this genetic marker in the disease pathogenesis is recommended, as well as its integration into clinical practice for more precise diagnosis and the development of personalized treatment approaches.
References
Patel V, Singh MK, Mishra A. Nasopharyngeal Angiofibroma: Karyotyping Profile and Florescent In-Situ Hybridization Analysis with C-Myelocytomatosis, Tumor Suppressor p53 and CEP-X/Y Probes. Indian Journal of Otolaryngology and Head & Neck Surgery. 2024;1–7.
Parra JEV, Barros KFO, Roldan HXG, Benavides JAV. Juvenile nasopharyngeal angiofibroma: A clinical case report and a literature review. World J Adv Res Rev [Internet]. 2024;22(3):1693–700. Available from: http://dx.doi.org/10.30574/wjarr.2024.22.3.1835
Gautham K, Ogale SB, Shraddha RU, Ajay D. Expression of GSTM1 in angiofibromas. J Laryngol Otol [Internet]. 2002;116(5):352–4. Available from: http://dx.doi.org/10.1258/0022215021910997
Coutinho-Camillo CM, Brentani MM, Nagai MA. Genetic alterations in juvenile nasopharyngeal angiofibromas. Head Neck [Internet]. 2008;30(3):390–400. Available from: http://dx.doi.org/10.1002/hed.20775
Makhasana JAS, Kulkarni MA, Vaze S, Shroff AS. Juvenile nasopharyngeal angiofibroma. J Oral Maxillofac Pathol [Internet]. 2016;20(2):330. Available from: http://dx.doi.org/10.4103/0973-029X.185908
Gupta S, Gupta S, Ghosh S, Narang P. Juvenile Nasopharyngeal Angiofibroma: Case report with review on role of imaging in diagnosis. Contemp Clin Dent [Internet]. 2015;6(1):98–102. Available from: http://dx.doi.org/10.4103/0976-237X.149301
Sánchez-Romero C, Carlos R, Díaz Molina JP, Thompson LDR, de Almeida OP, Rumayor Piña A. Nasopharyngeal Angiofibroma: A Clinical, Histopathological and Immunohistochemical Study of 42 Cases with Emphasis on Stromal Features. Head Neck Pathol [Internet]. 2018;12(1):52–61. Available from: http://dx.doi.org/10.1007/s12105-017-0824-z
Newman M, Nguyen TBV, McHugh T, Reddy K, Sommer DD. Early-onset juvenile nasopharyngeal angiofibroma (JNA): a systematic review. J Otolaryngol Head Neck Surg [Internet]. 2023;52(1):85. Available from: http://dx.doi.org/10.1186/s40463-023-00687-w
Sivapathasundharam B, Muthukumar RS. Nonepithelial tumors of the oral cavity. Shafer’s Textbook of Oral Pathology E-book. 193AD.
Ontiveros AH, Gregori EE, Vallano LC, Rodero SR, Velázquez AA, Julián JS. Juvenile nasopharyngeal angiofibroma with orbital extension. Archivos de la Sociedad Española de Oftalmología. 2015;90(1):22–5.
Alimli AG, Ucar M, Oztunali C, Akkan K, Boyunaga O, Damar C, et al. Juvenile nasopharyngeal angiofibroma: Magnetic Resonance Imaging findings. J Belg Soc Radiol [Internet]. 2016;100(1):63. Available from: http://dx.doi.org/10.5334/jbr-btr.1090
Gołąbek W, Szymańska A, Szymański M, Czekajska-Chehab E, Jargiełło T. Juvenile nasopharyngeal angiofibroma with intracranial extension-diagnosis and treatment. Polish Journal of Otolaryngology. 2020;74(2):1–7.
Kothari DS, Linker LA, Tham T, Maroda AJ, McElfresh JM, Fastenberg JH, et al. Preoperative embolization techniques in the treatment of juvenile nasopharyngeal angiofibroma: A systematic review. Otolaryngol Head Neck Surg [Internet]. 2023;169(3):454–66. Available from: http://dx.doi.org/10.1002/ohn.303
Doody J, Adil EA, Trenor CC 3rd, Cunningham MJ. The genetic and molecular determinants of juvenile nasopharyngeal angiofibroma: A systematic review. Ann Otol Rhinol Laryngol [Internet]. 2019;128(11):1061–72. Available from: http://dx.doi.org/10.1177/0003489419850194
López F, Triantafyllou A, Snyderman CH, Hunt JL, Suárez C, Lund VJ, et al. Nasal juvenile angiofibroma: Current perspectives with emphasis on management: Management of juvenile angiofibroma. Head Neck [Internet]. 2017;39(5):1033–45. Available from: http://dx.doi.org/10.1002/hed.24696
Scollon S, Anglin AK, Thomas M, Turner JT, Wolfe Schneider K. A comprehensive review of pediatric tumors and associated cancer predisposition syndromes. J Genet Couns [Internet]. 2017;26(3):387–434. Available from: http://dx.doi.org/10.1007/s10897-017-0077-8
Pruteanu DP, Olteanu DE, Cosnarovici R, Mihut E, Nagy V. Genetic predisposition in pediatric oncology. Med Pharm Rep [Internet]. 2020;93(4):323–34. Available from: http://dx.doi.org/10.15386/mpr-1576
Alshaikh NA, Eleftheriadou A. Juvenile nasopharyngeal angiofibroma staging: An overview. Ear Nose Throat J [Internet]. 2015;94(6):E12-22. Available from: http://dx.doi.org/10.1177/014556131509400615
Peraza-Mcliberty RA, Cortés-Benavides MC, Ml GAG. Interdisciplinary management of juvenile nasopharyngeal angiofibroma: presurgical embolization, surgical approach, and analysis of the literature. InAnales de Radiología. 2018;20–9.
Uetz S, Crosby DL. Current management of juvenile nasopharyngeal angiofibroma. Current Treatment Options in Allergy. 2020;7:335–46.
Mishra A, Pandey A, Mishra SC. Variable expression of molecular markers in juvenile nasopharyngeal angiofibroma. J Laryngol Otol [Internet]. 2017;131(9):752–9. Available from: http://dx.doi.org/10.1017/S0022215117001372
Chatterjee A, Gupta S. The multifaceted role of glutathione S-transferases in cancer. Cancer Lett [Internet]. 2018;433:33–42. Available from: http://dx.doi.org/10.1016/j.canlet.2018.06.028
Paulson KE. Xenobiotic Regulation of Glutathione S-Transferase Ya Gene Expression. In: Induced Effects of Genotoxic Agents in Eukaryotic Cells. CRC Press; 2020. p. 1–20.
Kim Y, Cha SJ, Choi HJ, Kim K. Omega class glutathione S-transferase: antioxidant enzyme in pathogenesis of neurodegenerative diseases. Oxidative medicine and cellular longevity. 2017;2017.
Dai X, Bui DS, Lodge C. Glutathione S-transferase gene associations and gene-environment interactions for asthma. Curr Allergy Asthma Rep [Internet]. 2021;21(5):31. Available from: http://dx.doi.org/10.1007/s11882-021-01005-y
Ding Z, Wang K, Li J, Tan Q, Tan W, Guo G. Association between glutathione S-transferase gene M1 and T1 polymorphisms and chronic obstructive pulmonary disease risk: A meta-analysis. Clin Genet [Internet]. 2019;95(1):53–62. Available from: http://dx.doi.org/10.1111/cge.13373
Shokrzadeh M, Ahangar N, Mohammadpour A, Golmohammadzadeh G. A Review of GENETIC Polymorphism of GSTs (Glutathione-s Transferase) Genes in Breast Cancer. Journal of Pharmaceutical Research International. 2019;29(6):1–12.
Johnson IT. Cruciferous vegetables and risk of cancers of the gastrointestinal tract. Mol Nutr Food Res [Internet]. 2018;62(18):1701000. Available from: http://dx.doi.org/10.1002/mnfr.201701000
Khosravi MH, Sharafi H, Alavian SM. Association of GSTM1 and GSTT1 null deletions and GSTP1 rs1695 polymorphism with the risk of hepatocellular carcinoma: A systematic review and meta-analysis. Hepat Mon [Internet]. 2021;20(11). Available from: http://dx.doi.org/10.5812/hepatmon.105632
Rajabi-Moghaddam M, Abbaszadeh H. Gene polymorphisms and risk of head and neck squamous cell carcinoma: a systematic review. Rep Pract Oncol Radiother [Internet].2022;27(6):1058–76. http://dx.doi.org/10.5603/RPOR.a2022.0115
Li W, Ni Y, Lu H, Hu L, Wang D. Current perspectives on the origin theory of juvenile nasopharyngeal angiofibroma. Discov Med. 2019;27(150):245–54.
Jia W-H, Shao J-Y, Feng B-J, Zeng Y-X. Genetic component involved in nasopharyngeal carcinoma development. Cancer Rev [Internet]. 2003;01(01):31–49. Available from: http://dx.doi.org/10.1142/s0219836303000098
Хамракулова, Н. О., Хушвакова, Н. Ж., Исхакова, Ф. Ш., & Тургунов, Б. Ш. (2016). ВЫБОР ТАКТИКИ ЛЕЧЕНИЯ БОЛЬНЫХ ХРОНИЧЕСКИМ ГНОЙНЫМ СРЕДНИМ ОТИТОМ ИСХОДЯ ИЗ ОСОБЕННОСТЕЙ ЕГО ТЕЧЕНИЯ. In Научные механизмы решения проблем инновационного развития (pp. 233-239).
Хушвакова, Н., Очилов, Т., & Хамракулова, Н. (2020). Сравнительная оценка результатов лечения больных с хроническим одонтогенным верхнечелюстным синуситом. Журнал стоматологии и краниофациальных исследований, 1(1), 68-71.
Khushvakova, N. J., & Khamrakulova, N. O. (2015, September). Local complex treatment experience for patients with chronic purulent otitis media. In CBU International Conference Proceedings (Vol. 3, pp. 444-446).
